|
HS Code |
372839 |
| Generic Name | Roxatidine Acetate Hydrochloride |
| Drug Class | H2 receptor antagonist |
| Chemical Formula | C19H28N4O8S·HCl |
| Molecular Weight | 525.97 g/mol |
| Route Of Administration | Oral |
| Therapeutic Indication | Peptic ulcer disease, gastroesophageal reflux disease |
| Mechanism Of Action | Inhibits gastric acid secretion by blocking H2 receptors on gastric parietal cells |
| Dosage Form | Tablet, Capsule |
| Contraindications | Known hypersensitivity to roxatidine or similar agents |
| Side Effects | Headache, dizziness, diarrhea, rash |
As an accredited Roxatidine Acetate Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, opaque plastic bottle containing 100 tablets of Roxatidine Acetate Hydrochloride 75 mg, securely sealed with a tamper-evident cap. |
| Shipping | Roxatidine Acetate Hydrochloride is shipped in tightly sealed, light-resistant containers to protect it from moisture and contamination. It should be stored and transported at controlled room temperature, avoiding exposure to excessive heat or humidity. Appropriate labeling and documentation are provided to ensure safe and compliant handling during transit. |
| Storage | Roxatidine Acetate Hydrochloride should be stored in a tightly closed container at room temperature, ideally between 15°C and 30°C (59°F and 86°F). It must be kept away from moisture, direct sunlight, and sources of heat. Ensure the storage area is well-ventilated and the substance is protected from incompatible materials to maintain stability and efficacy. |
|
Purity 99%: Roxatidine Acetate Hydrochloride with purity 99% is used in pharmaceutical formulation of antiulcer drugs, where it ensures high bioavailability and consistent therapeutic efficacy. Particle size <10 μm: Roxatidine Acetate Hydrochloride with particle size less than 10 μm is used in oral tablet production, where it promotes rapid dissolution and uniform drug release. Stability at 25°C: Roxatidine Acetate Hydrochloride stable at 25°C is used in long-term storage of medicinal preparations, where it maintains potency and prevents degradation. Melting point 183-187°C: Roxatidine Acetate Hydrochloride with a melting point of 183-187°C is used in thermal processing during granulation, where it ensures structural integrity and product quality. Assay ≥98%: Roxatidine Acetate Hydrochloride with an assay of 98% or higher is used in compounding bulk substances, where it provides reliable dosage accuracy for clinical applications. Moisture content <1%: Roxatidine Acetate Hydrochloride with moisture content less than 1% is used in dry powder formulations, where it prevents clumping and enhances shelf life. Molecular weight 378.84 g/mol: Roxatidine Acetate Hydrochloride with molecular weight 378.84 g/mol is used in pharmacokinetic studies, where it enables precise dosing and predictable absorption profiles. Stability in light exposure: Roxatidine Acetate Hydrochloride with high stability under light exposure is used in transparent blister packaging, where it minimizes risk of photodegradation. Residue on ignition ≤0.1%: Roxatidine Acetate Hydrochloride with residue on ignition not exceeding 0.1% is used in injectable formulations, where it assures purity and minimizes contaminant risk. Solubility in water ≥100 mg/mL: Roxatidine Acetate Hydrochloride with water solubility of at least 100 mg/mL is used in liquid suspension preparations, where it allows for highly concentrated and readily dispensable solutions. |
Competitive Roxatidine Acetate Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Roxatidine Acetate Hydrochloride stands as a well-known medication for treating acid-related conditions in the stomach. Developed to address health issues linked with excess stomach acid, it belongs to the class of drugs known as H2-receptor antagonists. These medications work by reducing the amount of acid produced in the stomach lining, offering much-needed relief for patients struggling with persistent heartburn, ulcers, and certain forms of gastritis. As someone who has observed the impacts of digestive disorders in both clinical settings and among family members, I appreciate how access to medications like this improves day-to-day living for many people.
People often face recurring pain or discomfort due to acid reflux and peptic ulcers, disrupting meals, sleep, and general well-being. Roxatidine Acetate Hydrochloride supports patients in regaining control by addressing the root cause of these symptoms. By directly blocking histamine’s action on the stomach’s acid-producing cells, it brings both symptom relief and the healing of underlying tissue damage. The difference this makes for someone experiencing daily discomfort is substantial—regular meals become enjoyable again, and worries about sudden pain subside.
Pharmaceutical manufacturers produce Roxatidine Acetate Hydrochloride tablets in doses that allow for accurate and adaptable treatment plans. Tablets most often contain 75 mg or 150 mg of the active ingredient, designed for twice-daily or once-daily administration, depending on the diagnosis and patient needs. This range of dosing gives doctors flexibility to manage mild symptoms or stubborn, long-standing acid disorders. Some manufacturers also supply this medication as oral suspensions or injectable forms for individuals who struggle to swallow pills or require more immediate intervention.
Packaging frequently reflects practical use: blister packs or bottles that promote safe storage and easy identification. Tablets are meant to be taken whole with water, typically before or after meals, aligning smoothly with daily routines for people on the go. As with most prescription medications, the manufacturing process follows strict medical standards and quality controls, prioritizing patient safety and reliable results.
Medication options for acid disorders have grown steadily over the years, with each class carrying unique attributes. As an H2-blocker, Roxatidine Acetate Hydrochloride differs from older antacids as well as proton pump inhibitors (PPIs). Where antacids quickly neutralize acid after meals or when symptoms strike, H2-blockers like Roxatidine actually reduce the production of acid in advance—helping to prevent episodes rather than just treating them when they appear.
PPIs often provide a stronger, longer-lasting reduction in stomach acid but require more time to reach full effectiveness, making them less suitable for those needing quick relief. They also bring other risks, such as higher chances of certain gut infections and trouble absorbing essential minerals when used for long periods. Roxatidine Acetate Hydrochloride starts working within about an hour and doesn’t demand such lengthy waits or risk profiles, providing a safe middle ground. As a result, doctors might choose this medication for new patients or those sensitive to the side effects linked to PPIs.
In daily language, patients often notice that Roxatidine causes fewer problems like bloating and does not raise worrying interactions with some food or drink, which can matter for people balancing multiple health concerns.
Stomach acid issues do not discriminate—children, teens, working adults, and seniors all experience discomfort related to heartburn, reflux, or ulcers at some point. Roxatidine Acetate Hydrochloride holds value because of its track record across this broad patient spectrum. For adults dealing with work or family obligations, having a pill that prevents late-night pain or lost sleep makes it easier to stay productive. In older adults, the lower likelihood of severe side effects or drug interactions supports safer long-term use.
Many parents worry about giving regular medication to their kids. As H2-blockers have gained more research backing, practitioners have prescribed adjusted doses to children under careful supervision, bringing a measure of comfort to families juggling chronic digestive issues with everyday school and play. For people caring for aging parents or spouses with complex medication needs, knowing that Roxatidine fits into various treatment regimens without major conflict takes some pressure off routine care.
My own introduction to Roxatidine came during a family member’s struggle with stubborn gastritis years ago. Weeks of dietary adjustments brought little relief, but regular use of this medication finally eased the constant burning that lingers after meals. The value extended beyond physical relief—the reduction in anxiety about food, social outings, or sleep issues was just as noticeable. Talking with peers in healthcare, similar stories echo, underscoring how prevention of pain and complications does more than just manage a symptom list—it improves the rhythms of daily life for the patient and those who share it.
Doctors often start with a trial course of Roxatidine Acetate Hydrochloride, observing symptom changes and healing progress over a few weeks. Some cases, like mild heartburn, respond quickly. Lower doses taken at night can prevent acid spikes that disrupt sleep, while higher, twice-daily regimens help address ulcers or erosive forms of gastritis. Health professionals regularly monitor patient response and can step down the dose or taper off use as tissues heal and symptoms settle.
Medication alone rarely solves the entire puzzle. People struggling with acid issues also work with their healthcare teams to adapt diet, improve stress management, and avoid known triggers—helping stretch the benefits of the medication and minimize recurrences. Teaching effective use—such as timing the pills with meals and recognizing early warning signs—improves the odds of long-term success.
No medication comes without some drawbacks, and it’s important to weigh these up front. Some individuals experience mild headaches, digestive upset, or dizziness with Roxatidine Acetate Hydrochloride. Rarely, allergic reactions or more serious side effects might appear. In a world where so many live with multiple prescriptions, both pharmacists and doctors watch for risks of unwanted interactions or compounded side effects. Patients should not self-prescribe or adjust doses without checking in with a professional, making honest sharing of any changes in health or medication crucial.
To address these risks, ongoing education forms a key part of responsible medication use. Healthcare providers receive regular updates on drug profiles, safe prescribing practices, and strategies for early detection of any trouble. Manufacturers continue to study new formulations and packaging to make dosing clearer and errors less likely. For everyday users, accessible written instructions and pharmacist advice can bridge the gap between clinical knowledge and daily practice. Communities benefit when open discussion about risks and benefits is encouraged, not avoided.
Certain patients, such as those with swallowing difficulties, cannot always take tablets easily. For these individuals, pharmaceutical research has spun off innovative forms—liquid suspensions or dissolvable films, for instance—that make accurate dosing possible without the struggle. Pediatric adjustments build on weight-based dosing, while higher-dose tablets meet the needs of adults with more difficult symptoms. Continuous feedback between patients, prescribers, and manufacturers is key to these advances, ensuring the supply chain adapts to real needs rather than theoretical standards.
Accessibility matters greatly. Many treatments for stomach acid issues exist, but not all prove affordable in the real world. Roxatidine Acetate Hydrochloride is produced by several reputable manufacturers, which tends to keep prices within reach of public healthcare systems and private payers. In regions where more expensive drugs are out of reach, it fills a critical gap, reducing the long-term burden of untreated acid disorders—which can otherwise leave people facing surgery, missed work, or dangerous complications. Improvements in distribution and funding ensure that even in rural or under-resourced settings, relief is not just for those in major cities.
Insurance plans increasingly include Roxatidine in their formularies, recognizing not just its direct benefits, but also its value in preventing far more costly consequences. Hospitalizations for bleeding ulcers, massive healthcare costs linked with chronic reflux disease, and the added strain of anxious nights spent in pain all drop with better management. By making this medication widely available, both patients and health systems share in the benefits of fewer emergencies and smoother recovery.
Community input shapes medical progress. Support groups, online forums, and even informal conversations among friends and family help share honest accounts of what it means to live with digestive disorders. Within these spaces, Roxatidine Acetate Hydrochloride frequently comes up as a reliable ally. Patients appreciate its predictable effects and the confidence that they can eat, travel, or rest without constant worry. Negative encounters—such as unwanted reactions or times when the drug alone didn’t provide enough relief—get discussed too, reminding us all that every treatment option has its limitations and opportunities for improvement.
Trust in a medication builds through transparency and honest dialogue. Doctors take the time to tailor choices and review ongoing research updates with patients. Pharmacists bridge gaps by clarifying instructions, flagging concerns, and ensuring that no ingredient or interaction goes unnoticed. Both the medical community and patients benefit when information flows freely.
As with any widely used medicine, verifying the source matters. Professional organizations and health authorities provide up-to-date guides on safe prescribing and detailed lists of approved manufacturers. Problems with counterfeit supplies or mislabeling have caused hardship in the past; in my experience, clear documentation, robust regulation, and habits of patient vigilance support safer outcomes. Patients and caregivers learn to look for trusted labels, check expiration dates, and consult with health professionals before starting or switching brands.
Up-to-date information empowers patients to participate actively in their own care. Modern tools for tracking symptoms, logging doses, and connecting with care teams turn passive recipients into engaged partners on the journey to better health. Information from reputable scientific reviews and regulatory agencies, rather than rumor or hearsay, reinforces best practices and reduces the odds of mistakes or missed opportunities for early intervention.
Medical science pushes onward, and the field of acid management is no exception. Ongoing research into better forms of H2-receptor antagonists, as well as side-by-side comparisons with new classes of drugs, continues to refine treatment strategies. Studies look closely for patterns in who responds best to Roxatidine Acetate Hydrochloride and how they fare over the long term—a crucial concern as chronic acid disorders often require years of vigilance.
Effort also continues to improve patient education and support resources. Language barriers, health literacy gaps, and difficulties getting to regular appointments all affect how well people manage ongoing stomach acid problems. Broadening the reach of telemedicine, plain-language instructions, and community-level support structures strengthens the partnership between patients and their medical teams. All of these elements contribute to safer, more reliable care pathways that uphold high standards for both quality and access.
While Roxatidine Acetate Hydrochloride brings measurable relief to those dealing with acid-related disorders, health does not depend on medicine alone. Medical teams stress the importance of supportive lifestyle shifts: balanced diets low in trigger foods, mindful stress management practices, and healthy routines for sleep and exercise. The willingness to combine consistent treatment with achievable daily habits increases the odds of long-term stability. My own observations—both inside clinics and around the dinner table—show that people who pair medication with targeted lifestyle goals report stronger, more lasting results.
Social supports matter here too. Family understanding and encouragement, clear communication with healthcare providers, and access to up-to-date advice all smooth the bumps that appear from time to time in chronic care. Doctors often schedule regular follow-ups—not just to refill prescriptions, but to review progress, discuss new research, and update care plans when life circumstances change.
Roxatidine Acetate Hydrochloride’s presence in the medication landscape demonstrates the value of steady, research-backed solutions for common health concerns. Its unique place among H2-blockers, flexible dosing options, and broad track record across ages and backgrounds make it a trusted choice for millions struggling with the daily disruptions of acid-related symptoms. Reliable access, clear and honest information, and ongoing collaboration between patients, providers, and manufacturers will remain the foundation for even better care tomorrow.
Practical, affordable, and flexible enough for a variety of patient needs, Roxatidine Acetate Hydrochloride continues to meet the demands of modern digestive health. Its growing role in clinical practice stands as a testament to sound science, careful stewardship, and the collective experience of those seeking not just symptom control, but genuine improvements in daily living.